BTG (BTG)

Sector:

Pharma and Biotech

Index:

FTSE 250

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

672.00p
   
  • Change Today:
    -5.50p
  • 52 Week High: 779.00
  • 52 Week Low: 563.50
  • Currency: UK Pounds
  • Shares Issued: 386.47m
  • Volume: 69,209
  • Market Cap: 2,597.05m

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 10.1% 24.9%
ROCE 24.7%  
Latest F'cast
P/E 29.3 23.4
PEG 5.4 0.9
Pr/Revenue 4.6 4.3
Pr/Book 2.7  
Latest F'cast
Revenue 27.5% 7.3%
PBT -45.0% 382.5%
EPS 5.5% 26.0%
DPS n/a n/a

BTG Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-13 233.70 24.10 14.50p 24.6 0.9 +27% n/a 0.0%
31-Mar-14 290.50 33.30 14.50p 37.4 n/a n/a n/a 0.0%
31-Mar-15 367.80 26.70 15.70p 45.5 5.7 +8% n/a 0.0%
31-Mar-16 447.50 57.50 21.90p 28.4 0.7 +40% n/a 0.0%
31-Mar-17 570.50 31.60 23.10p 25.4 4.2 +6% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

BTG Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 612.40 152.48 29.10p 23.3 0.9 +26% n/a 0.0%
31-Mar-19 636.96 164.82 32.60p 20.8 1.7 +12% n/a 0.0%
31-Mar-20 683.46 202.34 37.04p 18.3 1.3 +14% n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

BTG Company Announcements

Holding(s) in Company 16-Feb-2018 10:30 RNS
Total Voting Rights 01-Feb-2018 11:32 RNS
Holding(s) in Company 30-Jan-2018 16:38 RNS

Latest BTG Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

BTG Market Data

Currency UK Pounds
Share Price 672.00p
Change Today -5.50p
% Change -0.81 %
52 Week High 779.00
52 Week Low 563.50
Volume 69,209
Shares Issued 386.47m
Market Cap 2,597.05m

BTG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.92% below the market average83.92% below the market average83.92% below the market average83.92% below the market average83.92% below the market average
14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average
Price Trend
38.52% above the market average38.52% above the market average38.52% above the market average38.52% above the market average38.52% above the market average
44.62% above the sector average44.62% above the sector average44.62% above the sector average44.62% above the sector average44.62% above the sector average
Income Not Available
Growth
51.87% above the market average51.87% above the market average51.87% above the market average51.87% above the market average51.87% above the market average
30.23% below the sector average30.23% below the sector average30.23% below the sector average30.23% below the sector average30.23% below the sector average

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BTG Dividends

No dividends found

Trades for 22-Feb-2018

Time Volume / Share Price
12:50 526 @ 672.00p
12:50 532 @ 671.50p
12:50 3 @ 671.00p
12:50 416 @ 671.00p
12:50 131 @ 671.00p

BTG Key Personnel

CEO Dame Pamela Louise Makin
CFO Rolf Soderstrom
Chair Garry Watts
CFO Duncan Kennedy

Top of Page